Diamyd Medical receives positive feedback from FDA on potential Accelerated Approval for Diamyd® in Type 1 Diabetes ...Middle East

PR Newswire - News
STOCKHOLM , July 23, 2024 /PRNewswire/ -- Diamyd Medical received encouraging feedback from the U.S. Food and Drug Administration (FDA) regarding an Accelerated Approval pathway for its immunotherapy, Diamyd®, for treating patients with Stage 3 Type 1 Diabetes carrying the genotype HLA...

Hence then, the article about diamyd medical receives positive feedback from fda on potential accelerated approval for diamyd in type 1 diabetes was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Diamyd Medical receives positive feedback from FDA on potential Accelerated Approval for Diamyd® in Type 1 Diabetes )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News